XML 39 R6.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Beginning Balance (in shares) at Dec. 31, 2017   37,729      
Beginning Balance at Dec. 31, 2017 $ 1,191,971 $ 377 $ 266,035 $ 1,045,774 $ (120,215)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 38,945     38,945  
Other comprehensive loss:          
Cumulative translation adjustment 10,446       10,446
Issuance of common stock in connection with:          
Exercise of options (in shares)   153      
Exercise of options 5,794 $ 1 5,793    
Restricted share grants, less net settled shares (in shares)   175      
Restricted share grants, less net settled shares (1,579) $ 2 (1,581)    
Stock units issued under incentive compensation plan 1,059   1,059    
Purchase and retirement of common stock (in shares)   (337)      
Purchase and retirement of common stock (14,220) $ (3) (14,217)    
Share-based compensation 4,676   4,676    
Ending Balance (in shares) at Mar. 31, 2018   37,720      
Ending Balance at Mar. 31, 2018 1,237,434 $ 377 261,765 1,085,061 (109,769)
Beginning Balance (in shares) at Dec. 31, 2017   37,729      
Beginning Balance at Dec. 31, 2017 1,191,971 $ 377 266,035 1,045,774 (120,215)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 126,887        
Other comprehensive loss:          
Cumulative translation adjustment (17,417)        
Issuance of common stock in connection with:          
Stock units issued under incentive compensation plan 1,059        
Ending Balance (in shares) at Sep. 30, 2018   38,356      
Ending Balance at Sep. 30, 2018 1,351,475 $ 384 315,720 1,173,003 (137,632)
Beginning Balance (in shares) at Mar. 31, 2018   37,720      
Beginning Balance at Mar. 31, 2018 1,237,434 $ 377 261,765 1,085,061 (109,769)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 43,609     43,609  
Other comprehensive loss:          
Cumulative translation adjustment (23,683)       (23,683)
Issuance of common stock in connection with:          
Exercise of options (in shares)   360      
Exercise of options 14,806 $ 4 14,802    
Restricted share grants, less net settled shares (in shares)   99      
Restricted share grants, less net settled shares (252) $ 1 (253)    
Share-based compensation 3,887   3,887    
Ending Balance (in shares) at Jun. 30, 2018   38,179      
Ending Balance at Jun. 30, 2018 1,275,801 $ 382 280,201 1,128,670 (133,452)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 44,333     44,333  
Other comprehensive loss:          
Cumulative translation adjustment (4,180)       (4,180)
Issuance of common stock in connection with:          
Exercise of options (in shares)   340      
Exercise of options 13,569 $ 4 13,565    
Restricted share grants, less net settled shares (in shares)   33      
Restricted share grants, less net settled shares (835) $ 0 (835)    
Purchase and retirement of common stock (in shares)   (196)      
Purchase and retirement of common stock (15,000) $ (2) (14,998)    
Conversion feature of convertible senior notes due 2023, net 34,131   34,131    
Share-based compensation 3,656   3,656    
Ending Balance (in shares) at Sep. 30, 2018   38,356      
Ending Balance at Sep. 30, 2018 $ 1,351,475 $ 384 315,720 1,173,003 (137,632)
Beginning Balance (in shares) at Dec. 31, 2018 38,147 38,147      
Beginning Balance at Dec. 31, 2018 $ 1,348,825 $ 381 299,534 1,196,727 (147,817)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 62,645     62,645  
Other comprehensive loss:          
Cumulative translation adjustment 5,223       5,223
Issuance of common stock in connection with:          
Exercise of options (in shares)   55      
Exercise of options 2,212 $ 1 2,211    
Restricted share grants, less net settled shares (in shares)   153      
Restricted share grants, less net settled shares (2,739) $ 1 (2,740)    
Stock units issued under incentive compensation plan 1,346   1,346    
Purchase and retirement of common stock (in shares)   (328)      
Purchase and retirement of common stock (21,883) $ (3) (21,880)    
Share-based compensation 6,393   6,393    
Ending Balance (in shares) at Mar. 31, 2019   38,027      
Ending Balance at Mar. 31, 2019 $ 1,402,022 $ 380 284,864 1,259,372 (142,594)
Beginning Balance (in shares) at Dec. 31, 2018 38,147 38,147      
Beginning Balance at Dec. 31, 2018 $ 1,348,825 $ 381 299,534 1,196,727 (147,817)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 187,665        
Other comprehensive loss:          
Cumulative translation adjustment (16,225)        
Issuance of common stock in connection with:          
Stock units issued under incentive compensation plan $ 1,413        
Ending Balance (in shares) at Sep. 30, 2019 37,629 37,629      
Ending Balance at Sep. 30, 2019 $ 1,461,234 $ 376 240,508 1,384,392 (164,042)
Beginning Balance (in shares) at Mar. 31, 2019   38,027      
Beginning Balance at Mar. 31, 2019 1,402,022 $ 380 284,864 1,259,372 (142,594)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 64,598     64,598  
Other comprehensive loss:          
Cumulative translation adjustment (4,815)       (4,815)
Issuance of common stock in connection with:          
Exercise of options (in shares)   87      
Exercise of options 3,076 $ 1 3,075    
Restricted share grants, less net settled shares (in shares)   78      
Restricted share grants, less net settled shares (1,351) $ 1 (1,352)    
Purchase and retirement of common stock (in shares)   (580)      
Purchase and retirement of common stock (48,332) $ (6) (48,326)    
Share-based compensation 3,814   3,814    
Ending Balance (in shares) at Jun. 30, 2019   37,612      
Ending Balance at Jun. 30, 2019 1,419,012 $ 376 242,075 1,323,970 (147,409)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 60,422     60,422  
Other comprehensive loss:          
Cumulative translation adjustment (16,633)       (16,633)
Issuance of common stock in connection with:          
Exercise of options (in shares)   94      
Exercise of options 3,569 $ 1 3,568    
Restricted share grants, less net settled shares (in shares)   14      
Restricted share grants, less net settled shares (1,322) $ 0 (1,322)    
Stock units issued under incentive compensation plan 67   67    
Purchase and retirement of common stock (in shares)   (91)      
Purchase and retirement of common stock (7,734) $ (1) (7,733)    
Share-based compensation $ 3,853   3,853    
Ending Balance (in shares) at Sep. 30, 2019 37,629 37,629      
Ending Balance at Sep. 30, 2019 $ 1,461,234 $ 376 $ 240,508 $ 1,384,392 $ (164,042)